| Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007–15: Study examines pharmacy “deserts” in Black and Hispanic … JS Guadamuz, JR Wilder, MC Mouslim, SN Zenk, GC Alexander, DM Qato Health Affairs 40 (5), 802-811, 2021 | 78 | 2021 |
| Healthcare system distrust and the breast cancer continuum of care MC Mouslim, RM Johnson, LT Dean Breast cancer research and treatment 180, 33-44, 2020 | 43 | 2020 |
| Assessment of availability, clinical testing, and US Food and Drug Administration review of biosimilar biologic products TJ Moore, MC Mouslim, JL Blunt, GC Alexander, KM Shermock JAMA internal medicine 181 (1), 52-60, 2021 | 36 | 2021 |
| Low compliance from big hospitals on CMS’s hospital price transparency rule MA Henderson, MC Mouslim Health Affairs Forefront, 2021 | 27 | 2021 |
| Hospital And Regional Characteristics Associated With Emergency Department Facility Fee Cash Pricing: Study examines hospital and regional characteristics associated with … MA Henderson, MC Mouslim Health Affairs 41 (7), 1029-1035, 2022 | 14 | 2022 |
| Association between filgrastim biosimilar availability and changes in claim payments and patient out-of-pocket costs for biologic filgrastim products MC Mouslim, AJ Trujillo, GC Alexander, JB Segal Value in Health 23 (12), 1599-1605, 2020 | 12 | 2020 |
| Recommendations to the Society for Epidemiologic Research for further promoting diversity and inclusion at the annual meeting and beyond M Zhang, BA Jarrett, KN Althoff, FS Burman, L Camarata, SB Coburn, ... American journal of epidemiology 189 (10), 1037-1041, 2020 | 10 | 2020 |
| Assessing compliance with hospital price transparency over time M Henderson, M Mouslim Journal of General Internal Medicine 38 (9), 2218-2219, 2023 | 7 | 2023 |
| Dynamics of biosimilar uptake in emerging markets H Chhabra, MC Mouslim, S Kashiramka, AS Rathore Expert Opinion on Biological Therapy 22 (6), 679-688, 2022 | 4 | 2022 |
| Outpatient apheresis billing: A photopheresis model shows that hospital price transparency data remain difficult to interpret BD Adkins, GS Booth, JW Jacobs, H Jones, MC Mouslim, MA Henderson American journal of clinical pathology 160 (4), 404-410, 2023 | 2 | 2023 |
| Predictors of non-receipt of first-line CDK 4/6 inhibitors (CDK4/6i) among patients with metastatic breast cancer (MBC). KT Lee, E Chiao, D Lim, M Mouslim, C Wang, N Mangini, V Stearns, ... Journal of Clinical Oncology 39 (15_suppl), 1016-1016, 2021 | 2 | 2021 |
| Exploring the influence of health insurance plans on biosimilar adoption Rates J Costin, MC Mouslim, MP Socal, A Trujillo PharmacoEconomics-Open 8 (1), 115-118, 2024 | 1 | 2024 |
| Price variation for total shoulder arthroplasty in the United States: transparency, variability, and compliance with federal reporting regulations MJ Best, M Mouslim, M Henderson, S Sharma, AS Miller, GF Anderson, ... Seminars in Arthroplasty: JSES 33 (1), 169-173, 2023 | 1 | 2023 |
| The Price Paradox of Biosimilar-Like Long-Acting Insulin. MC Mouslim, ES Rashidi, JF Levy, MP Socal, AJ Trujillo American Journal of Managed Care 28 (11), 2022 | 1 | 2022 |
| How new data on hospital “discounted cash prices” might lead to patient savings MC Mouslim, MA Henderson Health Affairs Forefront, 2021 | 1 | 2021 |
| Facts About Hospital-Insurer Contracting. M Henderson, MC Mouslim American Journal of Managed Care 30 (2), 2024 | | 2024 |
| One Year Later, Where Are The'Transparency In Coverage'Compliance Studies? MA Henderson, MC Mouslim Health Affairs Forefront, 2023 | | 2023 |
| Transparency In Coverage: A New Tool For Promoting Provider Gender Equity? MC Mouslim, MA Henderson Health Affairs Forefront, 2023 | | 2023 |
| Effect of biosimilar market entry on cost of biologics in the United States: The case of filgrastim M Mouslim, C Alexander, J Segal PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 24-24, 2020 | | 2020 |
| Effect of biosimilar market entry on utilization of biologics in the united states: the case of filgrastim M Mouslim, J Segal PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 646-647, 2020 | | 2020 |
